相关实验视频
Updated: Jan 14, 2026

10:04
Enhancing Tumor Content through Tumor Macrodissection
Published on: February 12, 2022
12.1K
扩散型大B细胞淋巴瘤在长期性结肠炎的背景下发展:一个病例报告
Nhan Trung Phan1, Phat Tan Ho1, Nguyen Phuoc Ma1
1Department of Gastroenterology, Cho Ray Hospital, Ho Chi Minh City, Vietnam.
The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi
|October 24, 2025
概括
这项案例研究突出了患有性结肠炎 (UC) 的患者罕见的扩散性大B细胞淋巴瘤. 通过组织病理学早期诊断对于管理这种严重并发症至关重要.
科学领域:
- 胃肠病学 胃肠病学
- 在瘤学瘤学.
- 病理学 病理学 病理学
背景情况:
- 性结肠炎 (UC) 是一种慢性炎症性肠病.
- 长期UC可能会出现恶性并发症,淋巴瘤很少见.
- 从其他条件区分UC并发症可能是具有挑战性的.
研究的目的:
- 在患有性结肠炎 (UC) 的患者中报告一种罕见的扩散性大B细胞淋巴瘤 (DLBCL) 病例.
- 强调诊断挑战和管理转换需要在这种情况下.
- 突出在慢性UC患者具有异常表现的组织病理学评估的重要性.
主要方法:
- 一个46岁的女性病例报告,UC病史为8年.
- 用皮质类固醇和甘西克洛维尔治疗细胞巨乳病毒感染的初始治疗.
- 重复的结肠活检检查持续的血.
- 组织学检查和免疫组织化学染色用于诊断.
主要成果:
- 患者出现了急性严重的UC和持续的出血.
- 鉴定出细胞巨乳病毒感染并进行了部分治疗.
- 组织病理学证实了在UC的背景下产生的扩散性大B细胞淋巴瘤.
- 管理从抗TNF治疗转向化疗.
结论:
- 淋巴瘤是慢性UC患者的罕见但关键并发症.
- 在UC的非典型或部分响应性疾病过程中,需要对恶性瘤进行彻底的调查.
- 免疫组织化学对于UC患者的准确诊断和适当的治疗计划至关重要.
相关概念视频
Inflammatory Bowel Disease I: Ulcerative Colitis
891
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
891
Chronic Bowel Disorders: Introduction
744
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
744
Inflammatory Bowel Disease II: Crohn's Disease
947
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
947
Drugs for Treatment of Ulcerative Colitis in IBD
452
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
452
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
635
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
635
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
483
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
483

